Elanco Animal Health Incorporated (ELAN)

NYSE: ELAN · IEX Real-Time Price · USD
14.90
-0.04 (-0.27%)
Dec 29, 2023, 4:00 PM EST - Market closed
-0.27%
Market Cap 7.34B
Revenue (ttm) 4.36B
Net Income (ttm) -1.15B
Shares Out 492.80M
EPS (ttm) -2.32
PE Ratio n/a
Forward PE 17.14
Dividend n/a
Ex-Dividend Date n/a
Volume 3,369,064
Open 14.82
Previous Close 14.94
Day's Range 14.82 - 15.10
52-Week Range 7.88 - 15.10
Beta 1.14
Analysts Hold
Price Target 12.93 (-13.22%)
Earnings Date Feb 20, 2024

About ELAN

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more]

Sector Healthcare
IPO Date Sep 20, 2018
Employees 9,740
Stock Exchange NYSE
Ticker Symbol ELAN
Full Company Profile

Financial Performance

In 2022, ELAN's revenue was $4.41 billion, a decrease of -7.41% compared to the previous year's $4.76 billion. Losses were -$78.00 million, -83.85% less than in 2021.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ELAN stock is "Hold." The 12-month stock price forecast is $12.93, which is a decrease of -13.22% from the latest price.

Price Target
$12.93
(-13.22% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Ancora picks up a stake in Elanco. How the investor may push to help improve margins

A refreshment of the board may be on the horizon at the animal health company.

1 day ago - CNBC

Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president a...

12 days ago - Business Wire

Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice Presid...

4 weeks ago - Business Wire

Elanco Animal Health Reports Third Quarter 2023 Results

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2023, provided guidance for the fourth quarter of 2023, and ...

7 weeks ago - Business Wire

Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction

GREENFIELD, Ind. & INDIANAPOLIS--(BUSINESS WIRE)--Athian (athian.ai) announced today the establishment of the first-of-its-kind voluntary livestock carbon insetting marketplace, with the first accepte...

2 months ago - Business Wire

Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2023 financial results on Tuesday, November 7, 2023. Elanco will also conduct a confer...

2 months ago - Business Wire

Elanco Announces Corporate Governance Enhancements

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) announced today that the Board of Directors has commenced a process to amend the Company's corporate governing documen...

3 months ago - Business Wire

Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease

GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin™-CA1 (molidustat oral suspension), conditionally approved by U.S...

4 months ago - Business Wire

Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 and Tuesday, Sep...

4 months ago - Business Wire

Final Trades: Alphabet, Transocean & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: GOOGGOOGLRIG
4 months ago - CNBC Television

Stephanie Link's top stock picks: ELAN, CDW

Stephanie Link, Hightower Advisors chief investment strategist and portfolio manager, joins ‘Squawk Box' to discuss her recent stock picks, including Elanco Animal Health and CDW.

Other symbols: CDW
4 months ago - CNBC Television

Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2023, provided guidance for the third quarter of 2023, and ...

5 months ago - Business Wire

Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE:ELAN) today released its 2022 Environmental, Social and Governance (ESG) Report highlighting enhanced governance, transparenc...

5 months ago - Business Wire

Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2023 financial results on Monday, August 7, 2023. Elanco will also conduct a conferen...

5 months ago - Business Wire

Elanco says EPA affirms safety profile of its Seresto flea and tick collars

Elanco Animal Health said on Thursday the U.S. Environmental Protection Agency (EPA) has deemed the company's Seresto flea and tick collars for pets safe for use following a multi-year review.

6 months ago - Reuters

Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) and the U. S. Environmental Protection Agency (EPA) today announced that EPA, with support from the Food and Drug Admi...

6 months ago - Business Wire

Elanco and Tonisity International Expand Strategic Partnership into The Philippines

Greenfield, Indiana, Fort Collins, Colorado, Basel, Switzerland and Dublin, Ireland--(Newsfile Corp. - July 4, 2023) - Elanco Animal Health Incorporated (NYSE: ELAN) ("Elanco"), a global leader in ani...

6 months ago - Newsfile Corp

Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 44th Annual Global Healthcare Conference, June 12-13, 2023. Jeff Simmons, President and ...

7 months ago - Business Wire

Elanco to Participate in Stifel 2023 Jaws and Paws Conference

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Stifel 2023 Jaws and Paws Conference on Thursday, June 1, 2023. Todd Young, executive vice president a...

7 months ago - Business Wire

Elanco to Begin Distributing Tonisity's Gut Enhancing Swine Products Following Strategic Partnership Agreement

Dublin, Ireland--(Newsfile Corp. - May 19, 2023) - Elanco Animal Health Incorporated ("Elanco"), global leader in animal health, is set to begin distributing Tonisity International Ltd.'s ("Tonisity")...

8 months ago - Newsfile Corp

Elanco Animal Health Reports First Quarter 2023 Results

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the first quarter of 2023, provided guidance for the second quarter of 2023, and ...

8 months ago - Business Wire

Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has provided a conditional license for the first Canine Parv...

8 months ago - Business Wire

California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian

Athian's livestock carbon credit marketplace completes latest round of funding thanks to the investment by California Dairies, Inc. and DSM Venturing INDIANAPOLIS , May 1, 2023 /PRNewswire/ -- Athian ...

8 months ago - PRNewsWire

Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2023 financial results on Tuesday, May 9, 2023. Elanco will also conduct a conference ...

9 months ago - Business Wire

Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector

Will help fund ground-breaking solution to reward livestock producers for certified greenhouse gas reductions INDIANAPOLIS , March 14, 2023 /PRNewswire/ -- Athian (athian.ai), the world's first cloud-...

10 months ago - PRNewsWire